Evaluation of Nerve Regeneration After Nerve Transsection Using (Diffusion-tensor Magnetic Resonance Imaging) DTI MR Imaging

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Gustav Andreisek, University of Zurich
ClinicalTrials.gov Identifier:
NCT01020149
First received: November 23, 2009
Last updated: March 29, 2016
Last verified: March 2016
  Purpose
To prospectively evaluate the nerve regeneration after traumatic nerve transsection using diffusion tensor magnetic resonance imaging (DTI MR imaging).

Condition Intervention
Nerve Degeneration
Other: MR Imaging

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by University of Zurich:

Enrollment: 25
Study Start Date: January 2010
Study Completion Date: January 2016
Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)
Intervention Details:
    Other: MR Imaging
    MRI is used to evaluate nerve regeneration after traumatic transsection and nerve repair.
  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
primary care clinic
Criteria

Inclusion criteria:

  • Patients with traumatic nerve transsection and nerve repair.

Exclusion criteria:

  • contraindication for MRI;
  • pregnancy;
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01020149

Locations
Switzerland
Zurich, Switzerland
Sponsors and Collaborators
University of Zurich
Investigators
Study Director: 01 Studienregister MasterAdmins UniversitaetsSpital Zuerich
  More Information

Responsible Party: Gustav Andreisek, md, University of Zurich
ClinicalTrials.gov Identifier: NCT01020149     History of Changes
Other Study ID Numbers: 003 
Study First Received: November 23, 2009
Last Updated: March 29, 2016
Health Authority: Switzerland: Swissmedic

Keywords provided by University of Zurich:
Nerve transsection

Additional relevant MeSH terms:
Nerve Degeneration
Pathologic Processes

ClinicalTrials.gov processed this record on August 24, 2016